You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PI

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Improving Prostate Lesion Classification and Development

Completed
  • Prostate Cancer
    • Nuernberg, Germany
      Department of Radiology and Nuclear Medicine, Klinikum Nuernberg
    Nov 2, 2023

    Urinary Tract Infection, Acute Pyelonephritis Trial (TBP-PI-HBr, Imipenem-cilastatin, Dummy Infusion)

    Not yet recruiting
    • Urinary Tract Infection
    • Acute Pyelonephritis
    • (no location specified)
    Sep 22, 2023

    Gingival Inflammation Trial in Loma Linda (Toothpaste Tablet, Conventional Toothpaste)

    Completed
    • Gingival Inflammation
    • Toothpaste Tablet
    • Conventional Toothpaste
    • Loma Linda, California
      Loma Linda University
    Mar 28, 2023

    Alzheimer Trial in Hialeah, Maitland, Winter Park ([18F]PI-2620)

    Recruiting
    • Alzheimer Disease
    • Hialeah, Florida
    • +2 more
    Jan 18, 2023

    Cushing Disease Trial (Fimepinostat)

    Not yet recruiting
    • Cushing Disease
    • (no location specified)
    Jul 31, 2023

    Opioid-Related Disorders Trial in Philadelphia (18F-PI-2620 PET/CT)

    Not yet recruiting
    • Opioid-Related Disorders
    • 18F-PI-2620 PET/CT
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 13, 2023

    Melanoma Trial in Aurora (PI-88)

    Completed
    • Melanoma
    • Aurora, Colorado
      University of Colorado Health Sciences Center
    Jun 21, 2022

    Frontotemporal Lobar Degeneration, Alzheimer, Cognitively Normal Trial in Philadelphia ([18F]PI-2620)

    Not yet recruiting
    • Frontotemporal Lobar Degeneration
    • +2 more
    • Philadelphia, Pennsylvania
      Perelman Center for Advance Medicine
    Jul 13, 2022

    COPD (COPD), Alpha1-Antitrypsin Deficiency Trial (ARALAST NP, Another Available A1PI)

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Alpha1-Antitrypsin Deficiency
    • ARALAST NP
    • Another Available A1PI
    • (no location specified)
    Jul 18, 2022

    Alzheimer (AD) Trial in New Haven ([18F]GTP1, [18F]PI-2620, [18F]MK-6240)

    Recruiting
    • Alzheimer Disease (AD)
    • New Haven, Connecticut
      Invicro, a Konica Minolta company
    Aug 2, 2022

    Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

    Recruiting
    • Endometrial Cancer
    • Ovarian Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2022

    Carcinoma, Hepatocellular Trial in Taiwan (PI-88)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Kaohsiung, Taiwan
    • +5 more
    Jun 21, 2022

    Healthy Volunteers Trial (TBP-PI-HBr)

    Not yet recruiting
    • Healthy Volunteers
    • (no location specified)
    May 3, 2023

    Melanoma (Skin), Solid Tumor Trial in Australia, United States (PI-88)

    Completed
    • Melanoma (Skin)
    • Unspecified Adult Solid Tumor, Protocol Specific
    • Aurora, Colorado
    • +4 more
    Jun 21, 2022

    Perfusion; Complications, Arterial Catheterization, Peripheral Trial (radial artery cannulation)

    Not yet recruiting
    • Perfusion; Complications
    • Arterial Catheterization, Peripheral
    • radial artery cannulation
    • (no location specified)
    Oct 13, 2023

    Progressive Supranuclear Palsy Trial in Munich ([18F]-PI2620)

    Recruiting
    • Progressive Supranuclear Palsy
    • Munich, Germany
      Ludwig-Maximilians-Universität München
    Apr 7, 2022

    Pi Max and Diaphragm Maximum Inspiratory Excursion Detected With

    Recruiting
    • Weaning
    • +2 more
    • diaphragm ultrasound
    • Sabadell, Barcelona, Spain
      Candelaria De Haro
    Apr 26, 2022

    Mild Traumatic Brain Injury Trial run by the ([18F]PI-2620)

    Recruiting
    • Mild Traumatic Brain Injury
    • Bethesda, Maryland
      Walter Reed National Military Medical Center (WRNMMC)
    Apr 14, 2022

    Artificial Intelligence and Radiologists at Prostate Cancer

    Active, not recruiting
    • Prostate Cancer
    • Histopathology and Magnetic Resonance Imaging with Follow-Up
    • Histopathology and Magnetic Resonance Imaging
    • Nijmegen, Gelderland, Netherlands
      RadboudUMC
    Aug 3, 2022

    Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

    Active, not recruiting
    • Advanced Cancers
    • Solid Tumors
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 16, 2022

    Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)

    Not yet recruiting
    • Relapsed/Refractory Large Granular T Lymphocytic Leukemia
    • Zhoukou, Henan, China
    • +1 more
    Dec 22, 2022

    Hyperglycemia Drug Induced Trial in Durham (REMD-477)

    Terminated
    • Hyperglycemia Drug Induced
    • REMD-477
    • Durham, North Carolina
      Duke University Medical Center
    Nov 4, 2022

    Evaluation of the PI-RADS v2.1 Score Using Multiple Readers

    Completed
    • Prostate Cancer
    • Urological Cancer
    • Assessment of the accuracy of the PI-RADS v2.1 score for predicting the presence of ISUP ≥2 prostate cancer at subsequent biopsy in the dataset of the 171 MRIs for 21 different readers.
    • Lyon, France
      Hôpital Edouard Herriot
    Feb 28, 2022

    Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment Trial in Zhoukou, Tianjin (Linperlisib)

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
    • Failure of Two Rounds of Treatment
    • Zhoukou, Henan, China
    • +1 more
    Jan 7, 2023

    dapted Strategy Including Magnetic Resonance Imaging and

    Completed
    • Prostate Cancer
    • Prostate Adenocarcinoma
      • Ankara, Turkey
        Ankara University School of Medicine
      Sep 6, 2023